Sino Biopharmaceutical Li... (SBMFF)

PNK: SBMFF · Real-Time Price · USD

0.49

-0.00 (-0.81%)

At close: Apr 22, 2025, 10:13 AM

Sino Biopharmaceutical Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	23.02B	22.22B	19.32B	18.32B	25.12B	25.57B	26.03B	28.24B	27.7B	27.22B	26.86B	26.13B	25.35B	24.67B	23.65B	23.04B	24.35B	24.25B	24.23B	24.48B	23.69B	22.44B	20.89B	19.1B	17.06B	15.61B	14.82B	15.02B	14.78B	14.56B	14.2B	13.42B	13.13B	12.7B
Cost of Revenue	4.14B	4.02B	3.37B	2.71B	4.13B	4.31B	4.49B	5.67B	5.54B	5.4B	5.33B	5.15B	5.14B	5.33B	5.18B	5.23B	5.27B	4.98B	4.93B	4.88B	4.79B	4.47B	4.2B	3.78B	3.38B	3.22B	3.09B	3.14B	3.06B	3.03B	2.97B	2.82B	2.84B	2.82B
Gross Profit	18.87B	18.2B	15.95B	15.61B	20.99B	21.26B	21.54B	22.57B	22.16B	21.82B	21.53B	20.98B	20.21B	19.34B	18.46B	17.81B	19.09B	19.27B	19.31B	19.6B	18.9B	17.98B	16.69B	15.32B	13.68B	12.38B	11.73B	11.88B	11.72B	11.53B	11.23B	10.6B	10.29B	9.88B
Operating Income	5.17B	4.93B	3.99B	4.04B	5.4B	5.46B	5.53B	5.64B	5.3B	5.46B	5.09B	4.82B	4.9B	4.54B	4.33B	4.49B	5.09B	5.01B	5.09B	4.6B	4.72B	4.71B	4.61B	5.02B	4.28B	4.3B	3.93B	4.25B	4.52B	4.86B	4.71B	4.33B	3.89B	2.76B
Interest Income	3.08M	6.15M	21.67M	21.67M	37.18M	56.46M	75.73M	146.42M	217.12M	240.03M	271.73M	211.71M	179.99M	210.19M	233.45M	309.09M	307.53M	292.14M	257.71M	210.35M	200.91M	180.5M	162.72M	134.17M	117.16M	94.74M	83.06M	72.93M	55.56M	46.29M	40.67M	58.01M	66.7M	140.1M
Pretax Income	5.14B	4.86B	3.67B	3.5B	4.51B	4.86B	5.21B	8.56B	11.35B	17.61B	18.57B	16.05B	13.44B	6.59B	5.04B	4.87B	5.53B	5.64B	5.58B	11.64B	11.66B	11.58B	11.43B	5.46B	4.91B	4.52B	4.2B	3.95B	3.66B	3.54B	3.34B	3.18B	3.07B	2.95B
Net Income	3.65B	2.77B	1.09B	1.09B	1.4B	1.73B	2.06B	5.3B	8.05B	13.66B	14.61B	12.46B	10.04B	3.82B	2.78B	2.32B	2.49B	2.73B	2.71B	9.1B	9.13B	9.13B	9.05B	2.57B	2.44B	2.36B	2.17B	2.18B	1.95B	1.85B	1.7B	1.68B	1.6B	1.6B
Selling & General & Admin	10.07B	9.87B	8.4B	8.4B	11.22B	11.46B	11.71B	12.7B	12.85B	12.56B	12.59B	12.61B	12.59B	12.17B	11.6B	11.23B	11.63B	11.87B	11.91B	12.54B	11.8B	11.04B	10.27B	8.8B	7.92B	7.33B	6.9B	6.93B	6.87B	6.84B	6.81B	6.42B	6.45B	6.18B
Research & Development	3.76B	3.65B	3.41B	3.41B	4.55B	4.4B	4.24B	4.17B	4.01B	3.76B	3.75B	3.46B	2.87B	2.67B	2.63B	1.93B	1.97B	2.16B	2.05B	2.44B	2.39B	2.34B	2.09B	1.83B	1.77B	1.06B	1.06B	930.3M	616.66M	616.66M	479.7M	479.7M	479.7M	479.7M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-236.52M	-81.97M	-81.97M	168.91M	405.43M	250.88M	280.43M	29.55M	29.55M	41.04M	35.67M	-8.01M	-2.81M	-142.34M	-878.88M	-944.94M	-998M	-1.5B	-782.19M	-638.48M	-536.68M	444.51M
Operating Expenses	13.83B	13.52B	12.27B	12.27B	16.64B	16.51B	16.37B	16.84B	16.4B	17.91B	19.48B	19.2B	19.45B	17.17B	15.27B	14.46B	14.02B	14.29B	14.22B	15B	14.18B	13.4B	12.37B	10.59B	9.69B	8.24B	7.09B	6.92B	6.49B	5.96B	6.52B	6.27B	6.4B	7.12B
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	75.56M	147.22M	147.22M	238.36M	246.69M	265.46M	362.12M	318.04M	285.27M	229.95M	177.18M	188.33M	164.61M	153.26M	134.16M	94.98M	84.64M	77.94M	78.91M	86.01M	83.1M	80.2M	69.86M	60.18M	69.57M
Selling & Marketing Expenses	8.49B	8.28B	7.14B	7.14B	9.44B	9.62B	9.81B	10.48B	10.6B	10.34B	10.52B	10.2B	10.03B	9.54B	8.97B	8.59B	9B	9.36B	9.32B	9.41B	9.04B	8.55B	8.08B	7.43B	6.73B	6.27B	5.92B	6.05B	5.95B	5.88B	5.72B	5.43B	5.38B	5.2B
Cost & Expenses	17.85B	17.29B	15.63B	14.27B	20.07B	20.47B	20.86B	22.97B	22.4B	21.82B	21.78B	21.35B	20.73B	20.16B	19.4B	18.63B	19.11B	19.29B	19.16B	19.88B	18.99B	17.86B	16.57B	14.41B	13.07B	11.48B	10.22B	10.05B	9.54B	8.99B	9.49B	9.09B	9.24B	9.94B
Income Tax Expense	863.09M	805.04M	547.77M	521.02M	623.32M	660.02M	696.72M	984.17M	1.19B	1.8B	1.96B	1.54B	1.47B	907.07M	676.6M	839.1M	981.91M	893.71M	889.45M	744.27M	717.1M	749.86M	696.24M	822.22M	685.43M	545.25M	542.29M	583.39M	577.8M	539.17M	498.01M	488.57M	446.54M	461.45M
Shares Outstanding (Basic)	39.39B	39.39B	18.55B	18.55B	18.57B	18.57B	16.05B	21.03B	20.87B	20.87B	20.52B	20.52B	19.26B	20.62B	18.58B	18.87B	18.8B	23.76B	18.59B	18.88B	18.89B	18.89B	18.36B	18.94B	18.95B	17.96B	14.4B	17.44B	18.2B	16.68B	16.68B	16.68B	16.68B	16.68B
Shares Outstanding (Diluted)	18.41B	18.41B	18.57B	18.57B	18.56B	18.56B	18.91B	18.91B	19.12B	19.12B	19.28B	19.28B	19.29B	19.29B	18.58B	19.01B	19.49B	18.87B	18.6B	18.88B	18.89B	18.89B	18.36B	18.93B	18.96B	17.96B	14.4B	17.44B	18.2B	16.68B	16.68B	16.68B	16.68B	16.68B
EPS (Basic)	0.09	0.11	0.06	0.06	0.07	0.08	0.10	0.26	0.39	0.69	0.73	0.66	0.56	0.27	0.22	0.20	0.20	0.18	0.18	0.49	0.49	0.49	0.49	0.14	0.14	0.14	0.13	0.12	0.11	0.11	0.10	0.10	0.10	0.10
EPS (Diluted)	0.11	0.11	0.06	0.06	0.08	0.09	0.11	0.28	0.42	0.71	0.76	0.67	0.56	0.27	0.22	0.20	0.19	0.18	0.18	0.49	0.49	0.49	0.49	0.14	0.14	0.14	0.13	0.12	0.11	0.11	0.10	0.10	0.10	0.10
EBITDA	5.77B	5.6B	4.74B	4.74B	6.35B	6.3B	6.25B	6.16B	5.57B	12.01B	13.16B	13.47B	13.73B	7.32B	5.79B	5.65B	6.27B	5.92B	5.81B	5.28B	5.31B	5.21B	5.04B	5.59B	5B	4.6B	4.27B	4.02B	3.75B	3.62B	3.42B	3.25B	3.13B	3.02B
EBIT	4.99B	4.77B	3.9B	3.9B	5.26B	5.32B	5.39B	5.33B	4.77B	11.4B	12.74B	13.26B	13.73B	6.89B	5.36B	5.23B	5.85B	5.92B	5.81B	11.82B	11.85B	11.75B	11.58B	5.59B	5B	4.6B	4.27B	4.02B	3.75B	3.62B	3.42B	3.25B	3.13B	3.02B
Depreciation & Amortization	776.17M	830.59M	857.75M	836.39M	1.08B	975.69M	868.56M	832.95M	797.33M	808.95M	621.08M	410.29M	199.5M	421.57M	752.1M	752.1M	752.1M	330.53M	n/a	290.11M	290.11M	290.11M	290.11M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a